Company page

Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. (ticker: ESLA) is a public company based in the United States, with a market capitalization of approximately $40.9 million. The company focuses on developing innovative immunotherapy solutions. Estrella's commitment to advancing healthcare is reflected in its research and development efforts.